tiprankstipranks
Trending News
More News >
IDEAYA Biosciences Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsIDEAYA Biosciences Reports Q1 2025 Financial Results
1M ago
Ideaya Biosciences price target lowered to $37 from $40 at Oppenheimer
Premium
The Fly
Ideaya Biosciences price target lowered to $37 from $40 at Oppenheimer
1M ago
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
Premium
The Fly
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
1M ago
IDEAYA Biosciences: Promising Outlook with Regulatory Alignment and Strategic Expansion in Clinical Trials
PremiumRatingsIDEAYA Biosciences: Promising Outlook with Regulatory Alignment and Strategic Expansion in Clinical Trials
2M ago
Ideaya trial design consisent with guidance, says Oppenheimer
Premium
The Fly
Ideaya trial design consisent with guidance, says Oppenheimer
2M ago
Morning Movers: Goldman Sachs gains following first quarter results
Premium
The Fly
Morning Movers: Goldman Sachs gains following first quarter results
2M ago
Ideaya Biosciences granted breakthrough therapy designation for darovasertib
PremiumThe FlyIdeaya Biosciences granted breakthrough therapy designation for darovasertib
2M ago
Ideaya Biosciences announces research collaboration with Attmos
Premium
The Fly
Ideaya Biosciences announces research collaboration with Attmos
3M ago
Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures
Premium
Ratings
Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100